FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050557584> ?p ?o ?g. }

• W2050557584 endingPage "258" @default.
• W2050557584 startingPage "252" @default.
• W2050557584 abstract "We report the acute results and midterm clinical course after percutaneous transluminal septal myocardial ablation (PTSMA) in symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM).In the treatment of HOCM, surgical myectomy and DDD pacemaker therapy are considered the standard procedural extensions to drug therapy with negatively inotropic drugs. As an alternative nonsurgical procedure for reducing the left ventricular outflow tract (LVOT) gradient, PTSMA by alcohol-induced septal branch occlusion was introduced. However, clinical follow-up has not been sufficiently described.In 25 patients (13 women, 12 men; mean [+/- SD] age 54.7 +/- 15.0 years) who were symptomatic despite sufficient drug therapy, 1.4 +/- 0.6 septal branches were occluded with an injection of 4.1 +/- 2.6 ml of alcohol (96%) to ablate the hypertrophied interventricular septum. After 3-months, follow-up results of LVOT gradients and clinical course were determined.The invasively determined LVOT gradients could be reduced in 22 patients (88%), with a mean reduction from 61.8 +/- 29.8 mm Hg (range 4 to 152) to 19.4 +/- 20.8 mm Hg (range 0 to 74) at rest (p < 0.0001) and from 141.4 +/- 45.3 mm Hg (range 76 to 240) to 61.1 +/- 40.1 mm Hg (range 0 to 135) after extrasystole. All patients had angina pectoris for 24 h. The maximal creatine kinase increase was 780 +/- 436 U/liter (range 305 to 1,810) after 11.1 +/- 6.0 h (range 4 to 24). Thirteen patients (52%) developed a trifascicular block for 5 min to 8 days requiring temporary (n = 8 [32%]) or permanent (DDD) pacemaker implantation (n = 5 [20%]). An 86-year old woman died 8 days after successful intervention of uncontrollable ventricular fibrillation in conjunction with beta-sympathomimetics in chronically obstructive pulmonary disease. The remaining patients were discharged after 11.3 +/- 5.4 days (range 5 to 24), after an uncomplicated hospital course. Clinical and echocardiographic follow-up was achieved in all 24 surviving patients after 3 months. No cardiac complications occurred. Twenty-one patients (88%) showed clinical improvement, with a New York Heart Association functional class of 1.4 +/- 1.1. A further reduction in LVOT gradient was shown in 14 patients (58%).PTSMA of HOCM is a promising nonsurgical technique for septal myocardial reduction, with a consecutive reduction in LVOT gradient. Possible complications are trifascicular blocks, requiring permanent pacemaker implantation, and tachycardiac rhythm disturbances. Clinical long-term observations of larger patient series and a comparison with conventional forms of therapy are necessary to determine the conclusive therapeutic significance." @default.
• W2050557584 created "2016-06-24" @default.
• W2050557584 creator A5003704679 @default.
• W2050557584 creator A5011274028 @default.
• W2050557584 creator A5020291980 @default.
• W2050557584 creator A5051683694 @default.
• W2050557584 creator A5067245372 @default.
• W2050557584 creator A5083827525 @default.
• W2050557584 date "1998-02-01" @default.
• W2050557584 modified "2023-10-01" @default.
• W2050557584 title "Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy: Acute Results and 3-Month Follow-Up in 25 Patients" @default.
• W2050557584 cites W130919722 @default.
• W2050557584 cites W1970576771 @default.
• W2050557584 cites W1989018790 @default.
• W2050557584 cites W1996785634 @default.
• W2050557584 cites W2008092187 @default.
• W2050557584 cites W2013427674 @default.
• W2050557584 cites W2013673676 @default.
• W2050557584 cites W2024053445 @default.
• W2050557584 cites W2028018166 @default.
• W2050557584 cites W2036162164 @default.
• W2050557584 cites W2038802441 @default.
• W2050557584 cites W2048002035 @default.
• W2050557584 cites W2053780816 @default.
• W2050557584 cites W2055812524 @default.
• W2050557584 cites W2056730146 @default.
• W2050557584 cites W2057502735 @default.
• W2050557584 cites W2060440069 @default.
• W2050557584 cites W2068967760 @default.
• W2050557584 cites W2075320630 @default.
• W2050557584 cites W2085618217 @default.
• W2050557584 cites W2085720683 @default.
• W2050557584 cites W2088936448 @default.
• W2050557584 cites W2094252831 @default.
• W2050557584 cites W2129555327 @default.
• W2050557584 cites W2133802254 @default.
• W2050557584 cites W2140908730 @default.
• W2050557584 cites W2146049653 @default.
• W2050557584 cites W2152663914 @default.
• W2050557584 cites W2169652516 @default.
• W2050557584 cites W2235681635 @default.
• W2050557584 cites W2320518758 @default.
• W2050557584 doi "https://doi.org/10.1016/s0735-1097(97)00508-1" @default.
• W2050557584 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9462563" @default.
• W2050557584 hasPublicationYear "1998" @default.
• W2050557584 type Work @default.
• W2050557584 sameAs 2050557584 @default.
• W2050557584 citedByCount "227" @default.
• W2050557584 countsByYear W20505575842012 @default.
• W2050557584 countsByYear W20505575842013 @default.
• W2050557584 countsByYear W20505575842014 @default.
• W2050557584 countsByYear W20505575842015 @default.
• W2050557584 countsByYear W20505575842016 @default.
• W2050557584 countsByYear W20505575842018 @default.
• W2050557584 countsByYear W20505575842019 @default.
• W2050557584 countsByYear W20505575842021 @default.
• W2050557584 countsByYear W20505575842022 @default.
• W2050557584 crossrefType "journal-article" @default.
• W2050557584 hasAuthorship W2050557584A5003704679 @default.
• W2050557584 hasAuthorship W2050557584A5011274028 @default.
• W2050557584 hasAuthorship W2050557584A5020291980 @default.
• W2050557584 hasAuthorship W2050557584A5051683694 @default.
• W2050557584 hasAuthorship W2050557584A5067245372 @default.
• W2050557584 hasAuthorship W2050557584A5083827525 @default.
• W2050557584 hasBestOaLocation W20505575841 @default.
• W2050557584 hasConcept C126322002 @default.
• W2050557584 hasConcept C141071460 @default.
• W2050557584 hasConcept C155710745 @default.
• W2050557584 hasConcept C164705383 @default.
• W2050557584 hasConcept C2777361368 @default.
• W2050557584 hasConcept C2777473070 @default.
• W2050557584 hasConcept C2778198053 @default.
• W2050557584 hasConcept C2778797674 @default.
• W2050557584 hasConcept C2778921608 @default.
• W2050557584 hasConcept C2779740085 @default.
• W2050557584 hasConcept C2780127125 @default.
• W2050557584 hasConcept C2780185194 @default.
• W2050557584 hasConcept C2780813298 @default.
• W2050557584 hasConcept C2909003343 @default.
• W2050557584 hasConcept C2909789815 @default.
• W2050557584 hasConcept C71924100 @default.
• W2050557584 hasConceptScore W2050557584C126322002 @default.
• W2050557584 hasConceptScore W2050557584C141071460 @default.
• W2050557584 hasConceptScore W2050557584C155710745 @default.
• W2050557584 hasConceptScore W2050557584C164705383 @default.
• W2050557584 hasConceptScore W2050557584C2777361368 @default.
• W2050557584 hasConceptScore W2050557584C2777473070 @default.
• W2050557584 hasConceptScore W2050557584C2778198053 @default.
• W2050557584 hasConceptScore W2050557584C2778797674 @default.
• W2050557584 hasConceptScore W2050557584C2778921608 @default.
• W2050557584 hasConceptScore W2050557584C2779740085 @default.
• W2050557584 hasConceptScore W2050557584C2780127125 @default.
• W2050557584 hasConceptScore W2050557584C2780185194 @default.
• W2050557584 hasConceptScore W2050557584C2780813298 @default.
• W2050557584 hasConceptScore W2050557584C2909003343 @default.
• W2050557584 hasConceptScore W2050557584C2909789815 @default.
• W2050557584 hasConceptScore W2050557584C71924100 @default.
• W2050557584 hasIssue "2" @default.

• next